Form 4: Intuitive Surgical SVP Mark Brosius Executes Stock Sales Under 10b5-1 Trading Plan

Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, sold shares of ISRG common stock on October 25 and 28, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Mark Brosius, a Senior Vice President at Intuitive Surgical Inc. (ISRG), reported the sale of company stock.
• The transactions occurred on October 25 and October 28, 2024.
• On October 25, 2024, 22 shares of common stock were sold at a price of $514 per share.
• On October 28, 2024, 22 shares of common stock were sold at a price of $513.66 per share.
• Following these transactions, Brosius directly owns 185 shares of Intuitive Surgical stock.
• The sales were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1, set to expire on June 13, 2025.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to stock sales by an executive. The use of a 10b5-1 plan suggests the transactions were pre-planned and not indicative of any specific positive or negative sentiment regarding the company's prospects.

Positives

• The sales were executed under a pre-arranged 10b5-1 trading plan, indicating that the transactions were planned in advance and not based on insider information.

Future Outlook

The trading plan expires on June 13, 2025, suggesting further transactions may occur under this plan until that date.

Industry Context

Sales by executives are a normal part of corporate activity. The use of a 10b5-1 plan is a common practice to avoid insider trading concerns.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates